Pooling 48 randomised placebo-controlled trials (689 healthy adults), low caffeine doses of ≤3 mg·kg-1 shortened aerobic time-trial completion time (SMD -0.27), while moderate doses of 4-6 mg·kg-1 produced a larger and more consistent effect (SMD -0.52). No eligible trial reporting time-to-completion tested doses above 6 mg·kg-1.
What it shows: Meta-analysis of 48 randomised placebo-controlled trials in healthy adults aged 18-59 using acute oral anhydrous caffeine, but only 689 participants in total, effects pooled as standardised mean differences across varied time-trial protocols, and no trials of doses above 6 mg·kg-1 met the inclusion criteria, so the top of the dose range remains untested for this outcome.Meta-analysis · Nutrients